Skip Navigation


European Heart Journal Advance Access originally published online on March 10, 2008
European Heart Journal 2008 29(7):840-842; doi:10.1093/eurheartj/ehm594
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/7/840-a    most recent
ehm594v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stramba-Badiale, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stramba-Badiale, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy

Marco Stramba-Badiale*

Department of Rehabilitation Medicine, IRCCS Istituto Auxologico Italiano, Via Mosè Bianchi, 90, 20149 Milano, Italy

* Corresponding author. Tel: +39 02 619112850, Fax: +39 02 619112850, Email: stramba_badiale@auxologico.it

This editorial refers to ‘Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?’{dagger} by R. Nieuwlaat et al., on page 915

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 10% of the full text of this article appears below.

Despite a significant decline in the last 50 years, stroke remains the third leading cause of mortality in men and the second in women.1 Stroke also represents the leading cause of disability and the second of dementia, with a tremendous impact on the affected patients and their relatives. Approximately one-third of ischaemic strokes are caused by an embolus originating from the heart, and in the majority of these cases atrial fibrillation is responsible for the thromboembolic event. This proportion may be even higher, as the role of atrial fibrillation in the pathogenesis of stroke may be underestimated. In fact, the observation of sinus rhythm on the surface electrocardiogram at hospital admission for stroke, in the absence of clinical history . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
Robby Nieuwlaat, Trang Dinh, S. Bertil Olsson, A. John Camm, Alessandro Capucci, Robert G. Tieleman, Gregory Y.H. Lip, Harry J.G.M. Crijns, and on behalf of the Euro Heart Survey Investigators
EHJ 2008 29: 915-922. [Abstract] [FREE Full Text]